Jubilant Pharma to sell its 25.8 per cent stake in Sofie Biosciences for $139.43 mn
Of this, $113.63 million is expected to be received upon completion of the merger while receipt of balance sum of $25.8 million is…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Jubilant Pharmova
Jubilant gets additional loan from Canada Govt for expansion of CMO Montreal facility
Government of Canada to provide, through its Strategic Innovation Fund (SIF) program, a partially repayable loan of CAD 23.8…
Jubilant HollisterStier partners with Ocugen to make Covaxin for US, Canadian markets
Jubilant HollisterStier has manufacturing units in Spokane (US) and Montreal (Canada)
Jubilant Pharma subsidiary announces development of novel oral formulation of Remdesivir
The proposed oral treatment is expected to be for five days